Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31492995 | 0.81 | HSP90AA1 (0.34) | HSP90AA1HSP90AB1 | |
| SCHEMBL10889888 | 0.79 | HSP90AA1 (0.39) | HSP90AA1HSP90AB1 | |
| SCHEMBL30755868 | 0.79 | LMNA (0.36) | HSP90AA1HSP90AB1 | |
| SCHEMBL5219701 | 0.77 | ALDH1A1 (0.33) | — | |
| SCHEMBL11095538 | 0.71 | KDM4E (0.32) | HSP90AA1 | |
| SCHEMBL30755776 | 0.68 | MEN1 (0.33) | — | |
| SCHEMBL31493105 | 0.67 | ALDH1A1 (0.48) | — | |
| SCHEMBL20609571 | 0.65 | CNR1 (0.36) | — | |
| SCHEMBL609557 | 0.63 | HSP90AA1 (0.39) | HSP90AA1HSP90AB1 | |
| SCHEMBL9252957 | 0.63 | HTT (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028365-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | BIOGEN MA INC (US) | 2026-01-29 | — | — | US | disclosed |
| CN-119894879-A | Tyrosine kinase 2 inhibitors and uses thereof | 渤健马萨诸塞州股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028365-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | TYK2, ERBB2, ROS1 | HSP90AA1 1663/4885HSP90AB1 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.